Inhaled corticosteroids for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Balfour Lynn, Ian M ^a   Welch, Karen ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Department of Public Health Sciences ^*  (United Kingdom)

Author keywords

Administration, inhalation; Adult; Anti inflammatory agents *administration dosage ; Child; Cystic fibrosis *drug therapy ; Glucocorticoids *administration dosage ; Humans; Middle aged; Randomized controlled trials as topic

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE; BUDESONIDE; CARBENICILLIN; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; TOBRAMYCIN;

ABSCESS; ADULT; AGED; ANTIBIOTIC THERAPY; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; COUGHING; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; EXERCISE TOLERANCE; FEVER; FORCED EXPIRATORY VOLUME; GROWTH; HEMOPTYSIS; HOARSENESS; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; LUNG FUNCTION; META ANALYSIS; PATIENT COMPLIANCE; PHARYNGITIS; PNEUMONIA; PNEUMOTHORAX; PROGNOSIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; THORAX PAIN; THRUSH; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 67650037393     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001915.pub2     Document Type: Review

References (82)

1. Eichler I,Wojnarowski C, Frischer T, Renner S, Koller DY, GotzM. Inhaled corticosteroids suppress increased eosinophil cationic protein concentration in patients with cystic fibrosis [abstract]. Pediatric Pulmonology 1995;Suppl 12:326.
2. Wojnarowski C, Gotz M, Eichler HG, Frischer T, Koller DY, Eichler I. Topical steroid act anti-inflammatorily by patients with cystic fibrosis [abstract]. Monatsschrift Fur Kinderheilkunde. 1995; Vol.143:218.
3. * Wojnarowski C, GotzM, Eichler HG, Frischer T, Renner S, Koller DY, et al.Inhaled corticosteroids suppress inflammation in patients with cystic fibrosis [abstract]. Proceedings of the 20th European Cystic Fibrosis Conference; 1995 June 18-21; Brussels. 1995:P98.
4. * De Boeck K, De Baets F, Malfroot A, Desager K, Mouchet F, Proesmans M. Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?. European Journal of Pediatrics 2007;166(1):23-28
5. * Schmidt J, Davidson AGF, SeearM,Wong LTK, Peacock D, Gravelle A, et al.Is the acquisition of pseudomonads in cystic fibrosis patients increased by use of inhaled corticosteroids? Unexpected results from a double blind placebo controlled study [abstract]. Pediatric Pulmonology 1997;Suppl 14:293.
6. Balfour-Lynn IM, Lees B, Hall P, Phillips G, KhanM, Flather M, et al.CF WISE -Multicentre randomised controlled trial of withdrawal of inhaled corticosteroids [abstract]. Pediatric Pulmonology 2005;40 (Suppl 28):123-124
7. * Balfour-Lynn IM, Lees B,Hall P, Phillips G, KhanM, FlatherM, et al.Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. American Journal of Respiratory and Critical Care Medcine 2006;173(12):1356-1362
8. Schiotz P, JorgensenM,Winge Flensborg E, Fero O,Husby S,Hoiby N, et al.A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of CF patients: influence of local steroid treatment [abstract]. Proceedings of the 11th European Cystic Fibrosis Conference; 1982; Brussels. 1982:51.
9. * Schiotz PO, JorgensenM, Flensborg EW, Faero O,Husby S,Hoiby N, et al.Chronic Pseudomonas aeruginosa infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatrica Scandinavica 1983;72:283-287
10. Bisgaard H, Nielson K H, Sov M, Mosfeldt E, Bjerre B, Pedersen S, et al.Inhaled steroid treatment of CF patients with chronic pseudomonas aeruginosa (P.a.) lung infection [abstract]. Pediatric Pulmonology 1994;18(Suppl 10):395.
11. * BisgaardH, Pedersen SS,Nielsen KG, SkovM, Laursen EM, Kronborg G, et al.Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary pseudomonas aeruginosa infection. American Journal of Respiratory and Critical Care Medicine 1997;156(4 Pt 1):1190-1196
12. Bisgaard H, Petersen SS, Nielsen KG. Topical steroid treatment ameliorate lung pathophysiology of patients with cystic fibrosis and chronic pseudomonas AER [abstract]. European Respiratory Journal 1996;9(Suppl):174S.
13. * van Haren EH, Lammers JW, Festen J, Heijerman HG, Groot CA, van Herwaarden CL. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respiratory Medicine 1995;89(3):209-214
14. * Dauletbaev N, Viel K, Behr J, Loitsch S, Buhl R, Wagner TOF, Bargon J. Effects of short-term inhaled fluticasone on oxidative burst of sputumcells in cystic fibrosis patients. European Respiratory Journal 1999;14(5):1150-1155
15. * Hayes J,CosgraveC, O'ConnorC, FitzGeraldM. The effect of high dose inhaled corticosteroids on levels of sputum of plasma elastase and IL8 in patients with mild cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1995;151(4 Suppl):A248.
16. Hayes J,CosgraveC, O'ConnorC, FitzGeraldMX. The effect of high dose inhaled corticosteroids on levels of sputum or plasma elastase IL-8 in patients with mild cystic fibrosis. Irish Journal of Medical Science 1995;164(2):165.
17. Nikolaizik WH, Schoni MH. Effect of inhaled corticosteroids on lung function of cystic fibrosis patients - a prospective study [abstract]. European Respiratory Journal 1994;7:430S.
18. * Nikolaizik WH, Schoni MH. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. Journal of Pediatrics 1996;128(2):271-274
19. SchoniMH, Nikolaizik WH. Parallel group study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis [abstract]. Israel Journal of Medical Sciences 1996;32 Suppl: S190.
20. * Uyan ZS, Unluguzel G, Haklar G, Cakir E, Oktem S, Ersu R, et al.The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory parameters in patients with cystic fibrosis [abstract]. Journal Cystic Fibrosis 2008;7(Suppl 2):S68.
21. * Nieman R,Williams S,Maden C, Knight R,HodsonM. A double-blind placebo-controlled study comparing the effects of the inhaled corticosteroid fluticasone propionate 500 mcg BID with placebo in adults with cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine 1996;153:A72.
22. Balfour-Lynn I, Klein NJ, Dinwiddie R. Trial on inhaled corticosteroids (Fluticasone Propionate) in children with cystic fibrosis (CF) [abstract]. Israel Journal of Medical Sciences 1996;32 Suppl:S190.
23. Balfour-Lynn I, Klein N J, Dinwiddie, R. Sputum Interleukin-10 in Cystic Fibrosis [abstract]. Pediatric Pulmonology 1996;22(Suppl 13): 324.
24. * Balfour-Lynn I, Klein N J, Dinwiddie R. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Archives of Disease in Childhood 1997;77(2):124-130
25. Balfour-Lynn I, Klein NJ, Laverty A, Dinwiddie R. Effect of inhaled corticosteroids on airway nitric oxide levels in children with cystic fibrosis [abstract]. Pediatric Pulmonology 1996;22(Suppl 13):324.
26. * McElrea MS, O'Donnell SR, Francis PW. The effects of high-dose inhaled beclomethasone dipropionate (BDP) on lung function and sputum albumin in children with cystic fibrosis (CF) [abstract]. Pediatric Pulmonology 2000;30(Suppl 20):301.
27. * Wojtczak HA, Kerby GS, Wagener JS, Copenhaver SC, Gotlin RW, Riches DW, et al.Beclomethasone dipropionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study. Pediatric Pulmonology 2001;32(4):293-302.
28. Wotjczak HA, Wagener JS, Kerby G, Gotlin R, Accurso F. Effect of inhaled beclomethasone dipropionate on airway inflammation in children with cystic fibrosis [abstract]. Pediatric Pulmonology 1996;22(Suppl 13):323-324
29. * Wojtczak HA, Sontag MK,Wagener JS, Accurso FJ. Inhaled corticosteroid treatment in infants and young children with cystic fibrosis [abstract]. Pediatric Pulmonology 1999;28(Suppl 19):105-106
30. WojtczaKHA,Wagener JS, SontagMK,Accurso FJ. Bronchoalveolar lavage assessment of airway delivery of fluticasone propionate via pressurised metered dose inhaler in infants and young children with cystic fibrosis. Pediatric Pulmonology 1998;S19:341.
31. Association of the British Pharmaceutical Industry. Compendium of Data Sheets and Summaries of Product Characteristics 1999-2000. London: Datapharm Publications Ltd, 1999.
32. Armstrong DS, Greenwood K, Carzino JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly-diagnosed cystic fibrosis. BMJ 1995;310(6994):1570-1572
33. Balfour-Lynn IM, Dezateux C. Corticosteroids and ibuprofen in cystic fibrosis (letter). Thorax 1999;54(7):657. (Pubitemid 29296693)
34. Balfour-Lynn IM, Elborn JS. "CF asthma": what is it and what do we do about it?. Thorax 2002;57:742-748
35. Balfour-Lynn IM. Anti-inflammatory approaches to cystic fibrosis airways disease. Current Opinion in Pulmonary Medicine 2007;13:522-528 (Pubitemid 47494202)
36. Balfour-Lynn IM. Personal communication with UK CF Trust and CFF October 2008.
37. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatric Pulmonology 1995;20(2):63-70.
38. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. American Review of Respiratory Disease 1993;148(4 Pt 2):S1-26.
39. Booth H, Richmond I,Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. American Journal of Respiratory and Critical Care Medicine 1995;152(1):45-52.
40. Burdon JG, Cade JF, Sutherland PW, Pain MC. Cystic fibrosis and bronchial hyperreactivity: concomitant defects or cause and effect?. Medical Journal of Australia 1980;2(2):77-78
41. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. Journal of Allergy and Clinical Immunology 1997;100(4):452-457 (Pubitemid 27441299)
42. Cheng K, Ashby, Smyth R. Oral steroids for cystic fibrosis. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858]
43. Djukanovic R,Wilson JW, Britten KM,Wilson SI,Walls AF, Roche WR, et al.Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. American Review of Respiratory Disease 1992;145(3):669-674
44. Drake AJ, Howells RJ, Shield JPH, Prendiville A,Ward PS, Crowne PC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002;324(7345):1081-1082
45. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A.Meta-analysis involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31:140-149 (Pubitemid 34284916)
46. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, et al.Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. American Journal of Respiratory and Critical Care Medicine 2007;176(10):957-969
47. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57(10):875-879 (Pubitemid 35178612)
48. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. American Journal of Respiratory and Critical Care Medicine 2002;165(12):1592-1596 (Pubitemid 34693937)
49. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560
50. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
51. Hilliard TN, Balfour-Lynn IM. Anti-inflammatory agents a clinical perspective. In: Bush A editor(s). Progress in Respiratory Research Cystic Fibrosis. Basel: S Karger AG, 2005:187-194
52. Khan TZ, Wagner JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1995;151(4):1975-1982
53. Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J, et al.International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatric Pulmonology 1997;24(2):147-154. (Pubitemid 27450733)
54. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. American Journal of Respiratory Cell andMolecular Biology 2004;31(4):377-381 (Pubitemid 39330947)
55. KonstanMW,Hilliard KA, Norvell EM, BergerM. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. American Journal of Respiratory and Critical Care Medicine 1994;150(2):448-454
56. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA, for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Patterns of medical practice in cystic fibrosis: Part II. Use of therapies. Pediatric Pulmonology 1999;28(4):248-254
57. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Archives of Internal Medicine 1999;159(9):941-955
58. Macdessi JS, Randell TL, Donaghue KC, Ambler GR, Van Asperen PP, Mellis CM. Adrenal crises in children treated with high-dose inhaled corticosteroids for asthma. Medical Journal of Australia 2003;178(5):214-216 (Pubitemid 36329214)
59. Main KM, Skov M, Sillesen IB, Dige-Petersen H, Muller J, Koch C, et al.Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. Acta Pediatrica 2002;91(9):1008-1011 (Pubitemid 35168419)
60. Minicucci L, Severi G, Cresta L, Giannattasio A, Lorini R, Haupt R. Impact of inhaled corticosteroids on the risk of early Pseudomonas aeruginosa acquisition in cystic fibrosis. Acta Paediatica 2003;92(6):684-687 (Pubitemid 37088676)
61. Mitchell I, Corey M, Woenne R, Krastins IR, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. Journal of Pediatrics 1978;93(5):744-748 (Pubitemid 8397579)
62. Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, et al.Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatric Pulmonology 1999;28(4):231-241
63. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; Vol.59, issue Suppl 1.
64. Padman R, McColley SA, Miller DP, Konstan MW, Morgan WJ, Schechter MS, et al.Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007;119(3):e531-7. (Pubitemid 46407523)
65. Parmar JS, Howell T, Kelly J, Bilton D. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 2002;57(8):749-750 (Pubitemid 34864536)
66. Patel L,Wales JK, KibirigeMS,Massarano AA, Couriel JM, Clayton PE. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Archives of disease in childhood 2001;85(4):330-334
67. Patel H, Platt R, Lozano JM, Wang EEL. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858]
68. Renkema TE, Schouten UP, Koeter GH Postma DS. Effects of long-term treatment with corticosteroids in COPD. Chest 1996;109(5):1156-1162 (Pubitemid 26145649)
69. Russell G. The use of inhaled corticosteroids during childhood: plus ca change. Archives of Disease in Childhood 2004;89(10):893-895 (Pubitemid 39331374)
70. Schulz K, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-412
71. Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. European Respiratory Journal 2002;20 (1):127-133 (Pubitemid 34822934)
72. Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. British Journal of Opthalmology 2003;87(10):1247-1251 (Pubitemid 37193916)
73. Taylor AV, Laoprasert N, Zimmerman D, Sachs MI. Adrenal suppression secondary to inhaled fluticasone propionate. Annals of Allergy, Asthma & Immunology 1999;83(1):68-70. (Pubitemid 30336814)
74. Tobin MJ, Maguire D, Keen D, Tempany E, Fitzgerald MX. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980;35(11):807-813
75. Todd G, Dunlop K, McNaboe J, Ryan MF, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996;348(9019):27-29 (Pubitemid 26237242)
76. ToddGR, Acerini CL, Ross-Russell R, Zahra S,Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood 2002;87(6):457-461 (Pubitemid 35440691)
77. van Grunsven PM, van Schayck CP, Molema J, Akkermans RP, van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax 1999;54(4):316-322
78. Walters S. Association of cystic fibrosis adults (UK) Survey 1994 - Analysis and Report. Cystic Fibrosis Trust 1995.
79. Walters S. Personal communication June 14 2001.
80. Weir DC, Burge PS. Effects of high dose inhaled beclomethasone propionate 750 micrograms and 1500 micrograms twice daily and 40 mg per day oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 1993;48(4):309-316
81. Wojtczak HA, Kerby GS,Wagener JS, Copenhaver SC, Gotlin RW, Riches DW, et al.Beclomethasone dipropionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study. Pediatric Pulmonology 2001;32(4):293-302.
82. Zhang X, Moilanen E, Kankaanranta H. Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. European Journal of Pharmacology 2001;431(3):365-71. * Indicates the major publication for the study